Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

Department of Psychiatry, Faculty of Medicine, University of Montreal, Fernand-Seguin Research Center, Louis-H Lafontaine Hospital, Montreal, Quebec, Canada.
Biological psychiatry (Impact Factor: 9.47). 05/2008; 63(8):801-8. DOI: 10.1016/j.biopsych.2007.09.024
Source: PubMed

ABSTRACT Cytokines play an important role in infection and inflammation and are crucial mediators of the cross-talk between the brain and the immune system. Schizophrenia would be associated with an imbalance in inflammatory cytokines, leading to a decrease in Th1 and an increase in Th2 cytokine secretion. However, data published so far have been inconsistent. The primary objective of the present meta-analysis was to verify whether the cytokine imbalance hypothesis of schizophrenia is substantiated by evidence.
Cross-sectional studies were included if they assessed in vivo plasma or serum cytokine concentrations and/or in vitro secretion of cytokines by peripheral blood leukocytes from schizophrenia patients and healthy volunteers.
Data from 62 studies involving a total sample size of 2298 schizophrenia patients and 1858 healthy volunteers remained for analysis. Ten cytokines were assessed, including the prototypic Th1 and Th2 cytokines gamma interferon (IFN-gamma) and interleukin 4 (IL-4) as well as IL-2, soluble IL-2 receptor (sIL-2R), IL-1beta, IL-1 receptor antagonist (IL-1RA), tumor necrosis factor-alpha (TNF-alpha), IL-6, soluble IL-6 receptor (sIL-6R), and IL-10. The results show that an increase occurs in in vivo IL-1RA, sIL-2R, and IL-6 and a decrease occurs in in vitro IL-2 in schizophrenia. No significant effect sizes were obtained for the other cytokines.
These findings provide the first evidence of establishment of an inflammatory syndrome in schizophrenia, which refutes the current hypothesis of a Th2 slant. Caveats are presented to data interpretation, including the role of stress and the effect of weight gain that develops in schizophrenia.

Download full-text


Available from: Amir Sepehry, Aug 22, 2015
    • "Evidence supports infl ammatory alterations in major depressive disorder (MDD; Dowlati et al. 2010; Valkanova et al. 2013), schizophrenia (Potvin et al. 2008) and bipolar disorder (Modabbernia et al. 2013). Cytokines are important for brain development , and healthy brain function by supporting neuronal integrity, neurogenesis, and synaptic remodelling (Yirmiya and Goshen 2011), neurocircuitry and neurotransmitters to produce behavioural alterations (Haroon et al. 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Suicidal behaviour (SB) entered the DSM-5, underlying a specific biological vulnerability. Then, recent findings suggested a possible role of the immune system in SB pathogenesis. The objective of this review is to present these main immune factors involved in SB pathogenesis. We conducted a review using Preferred Reporting Items for Systematic reviews and Meta-Analysis criteria, and combined ("Inflammation") AND ("Suicidal ideation" OR "Suicidal attempt" OR "suicide"). Post mortem studies demonstrated associations between suicide and inflammatory cytokines in the orbitofrontal cortex, a brain region involved in suicidal vulnerability. Also, microgliosis and monocyte-macrophage system activation may be a useful marker of suicide neurobiology. Kynurenine may influence inflammatory processes, and related molecular pathways may be involved in SB pathophysiology. Few recent studies associated inflammatory markers with suicidal vulnerability: serotonin dysfunction, impulsivity and childhood trauma. Interestingly, the perception of threat that leads suicidal individuals to contemplate suicide may activate biological stress responses, including inflammatory responses. Translational projects would be crucial to identify a specific marker in SB disorders, to investigate its clinical correlations, and the interaction between inflammatory cytokines and monoamine systems in SB. These researches might lead to new biomarkers and novel directions for therapeutic strategies.
    The World Journal of Biological Psychiatry 07/2015; DOI:10.3109/15622975.2015.1054879 · 4.23 Impact Factor
  • Source
    • "The neural activities of pro-inflammatory cytokines are mainly mediated by microglia. There have been consistent reports that increased levels of pro-inflammatory cytokines and microglial activation are associated with schizophrenia (Miller et al., 2011; Potvin et al., 2008; van Berckel et al., 2008). Microglia are found in the CNS and account for approximately up to 20% of the glial cell population in the CNS (Lawson et al., 1992), with particularly high concentrations in the hippocampus, basal ganglia, and substantia nigra (Badoer, 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cytokines are pleiotropic molecules with important roles in inflammatory responses. Pro-inflammatory cytokines and neuroinflammation are important not only in inflammatory responses but also in neurogenesis and neuroprotection. Sustained stress and the subsequent release of pro-inflammatory cytokines lead to chronic neuroinflammation, which contributes to depression. Hippocampal glucocorticoid receptors (GR) and the associated hypothalamus-pituitary-adrenal (HPA) axis have close interactions with pro-inflammatory cytokines and neuroinflammation. Elevated pro-inflammatory cytokine levels and GR functional resistance are among the most widely investigated factors in the pathophysiology of depression. These two major components create a vicious cycle. In brief, chronic neuroinflammation inhibits GR function, which in turn exacerbates pro-inflammatory cytokine activity and aggravates chronic neuroinflammation. On the other hand, neuroinflammation causes an imbalance between oxidative stress and the antioxidant system, which is also associated with depression. Although current evidence strongly suggests that cytokines and GR have important roles in depression, they are essential components of a whole system of inflammatory and endocrine interactions, rather than playing independent parts. Despite the evidence that a dysfunctional immune and endocrine system contributes to the pathophysiology of depression, much research remains to be undertaken to clarify the cause and effect relationship between depression and neuroinflammation. Copyright © 2015. Published by Elsevier Inc.
    Progress in Neuro-Psychopharmacology and Biological Psychiatry 06/2015; DOI:10.1016/j.pnpbp.2015.06.008 · 4.03 Impact Factor
    • "A role for cytokines in schizophrenia was proposed nearly two decades ago (Smith 1992; Smith and Maes 1995), with many subsequent studies reporting alteration of the cytokine milieu in schizophrenia with the propensity for the production of proinflammatory cytokines (Ganguli et al. 1994; Maes et al. 1994, Maes et al. 1995). Meta-analyses of a large number cross-sectional studies now confirm that anti-psychotic naïve first episode psychosis and acute psychotic relapse are associated with increased serum levels of proinflammatory cytokines , such as IL-1β, IL-6, TNF-α and decreased serum levels of the anti-inflammatory cytokine, IL-10, which are normalised after remission of symptoms with anti-psychotic treatment (Miller et al. 2011; Potvin et al. 2008; Upthegrove et al. 2014). Serum IL-6 levels are associated with the severity and duration of illness (de Witte et al. 2014; Maes et al. 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia is characterised by hallucinations, delusions, depression-like so-called negative symptoms, cognitive dysfunction, impaired neurodevelopment and neurodegeneration. Epidemiological and genetic studies strongly indicate a role of inflammation and immunity in the pathogenesis of symptoms of schizophrenia. Evidence accrued over the last two decades has demonstrated that there are a number of pathways through which systemic inflammation can exert profound influence on the brain leading to changes in mood, cognition and behaviour. The peripheral immune system-to-brain communication pathways have been studied extensively in the context of depression where inflammatory cytokines are thought to play a key role. In this review, we highlight novel evidence suggesting an important role of peripheral immune-to-brain communication pathways in schizophrenia. We discuss recent population-based longitudinal studies that report an association between elevated levels of circulating inflammatory cytokines and subsequent risk of psychosis. We discuss emerging evidence indicating potentially important role of blood-brain barrier endothelial cells in peripheral immune-to-brain communication, which may be also relevant for schizophrenia. Drawing on clinical and preclinical studies, we discuss whether immune-mediated mechanisms could help to explain some of the clinical and pathophysiological features of schizophrenia. We discuss implication of these findings for approaches to diagnosis, treatment and research in future. Finally, pointing towards links with early-life adversity, we consider whether persistent low-grade activation of the innate immune response, as a result of impaired foetal or childhood development, could be a common mechanism underlying the high comorbidity between certain neuropsychiatric and physical illnesses, such as schizophrenia, depression, heart disease and type-two diabetes.
    Psychopharmacology 06/2015; DOI:10.1007/s00213-015-3975-1 · 3.99 Impact Factor
Show more

Similar Publications